Related Experiment Video

Updated: Jun 17, 2026

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
10:39

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache

Published on: June 2, 2014

Advances in paediatric migraine

Gerald Friedman1

  • 1Department of Paediatrics, York Central Hospital, Richmond Hill, Ontario.

Paediatrics & Child Health
|January 5, 2010
PubMed

Insights

Pediatric migraine is common, with most cases being primary headaches. Triptans, a serotonin agonist medication, are effective for treating acute migraines in children, aligning with adult treatment standards.

Area of Science:

  • Pediatric Neurology
  • Neuroscience
  • Pharmacology

Background:

  • Headaches are a frequent pediatric primary care complaint.
  • Most childhood headaches are primary syndromes like migraine or tension-type.
  • Parental concern often involves fear of serious underlying pathology.

Purpose of the Study:

  • To review recent advances in pediatric migraine.
  • To focus on epidemiology, diagnostic criteria, and pathophysiology.
  • To examine management strategies, including neuroimaging and triptan use.

Main Methods:

  • Review of current literature on pediatric migraine.
  • Analysis of evolving diagnostic criteria for children.
  • Examination of evidence for pharmacotherapy, specifically triptans.

Main Results:

  • Migraine is a prevalent primary headache disorder in children.
  • Diagnostic criteria for pediatric migraine are under revision.
  • Triptans demonstrate efficacy in treating acute pediatric migraines, similar to adults.

Conclusions:

  • Pediatric migraine management benefits from understanding evolving diagnostic criteria and pathophysiology.
  • Triptans represent an effective treatment option for acute pediatric migraines.
  • Further research supports the use of triptans in this population.

Keywords:
AdolescentsChildrenHeadacheMigraineSumatriptanTriptans

More Related Videos

An Automated Squint Method for Time-syncing Behavior and Brain Dynamics in Mouse Pain Studies05:49

An Automated Squint Method for Time-syncing Behavior and Brain Dynamics in Mouse Pain Studies

Published on: November 1, 2024

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...